b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">28109971</PMID>\n        <DateCompleted>\n            <Year>2017</Year>\n            <Month>08</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>17</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1555-7162</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>130</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2017</Year>\n                        <Month>06</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The American journal of medicine</Title>\n                <ISOAbbreviation>Am. J. Med.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>707-719.e8</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0002-9343(17)30035-9</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2017.01.004</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">The optimal on-treatment blood pressure (BP) target has been a matter of debate. The recent SPRINT trial showed significant benefits of a BP target of &lt;120 mm Hg, albeit with an increase in serious adverse effects related to low BP.</AbstractText>\n                <AbstractText Label="METHODS">PubMed, EMBASE, and CENTRAL were searched for randomized trials comparing treating\xc2\xa0with different BP targets. Trial arms were grouped into 5 systolic BP target categories: 1) &lt;160\xc2\xa0mm\xc2\xa0Hg,\xc2\xa02)\xc2\xa0&lt;150 mm Hg, 3) &lt;140 mm Hg, 4) &lt;130 mm Hg, and 5) &lt;120 mm Hg. Efficacy outcomes of stroke, myocardial infarction, death, cardiovascular death, heart failure, and safety outcomes of serious adverse effects were evaluated using a network meta-analysis.</AbstractText>\n                <AbstractText Label="RESULTS">Seventeen trials that enrolled 55,163 patients with 204,103 patient-years of follow-up were included. There was a significant decrease in stroke (rate ratio [RR] 0.54; 95% confidence interval [CI], 0.29-1.00) and myocardial infarction (RR 0.68; 95% CI, 0.47-1.00) with systolic BP &lt;120 mm Hg (vs &lt;160 mm Hg). Sensitivity analysis using achieved systolic BP showed a 72%, 97%, and 227% increase in stroke with systolic BP of &lt;140 mm Hg, &lt;150 mm Hg, and &lt;160 mm, respectively, when compared with systolic BP &lt;120 mm Hg. There was no difference in death, cardiovascular death, or heart failure when comparing any of the BP targets. However, the point estimate favored lower BP targets (&lt;120 mm Hg, &lt;130 mm Hg) when compared with higher BP targets (&lt;140 mm Hg or &lt;150 mm Hg). BP targets of &lt;120 mm Hg and &lt;130 mm Hg ranked #1 and #2, respectively, as the most efficacious target. There was a significant increase in serious adverse effects with systolic BP &lt;120 mm Hg vs &lt;150 mm Hg (RR 1.83; 95% CI, 1.05-3.20) or vs &lt;140 mm Hg (RR 2.12; 95% CI, 1.46-3.08). BP targets of &lt;140 mm Hg and &lt;150 mm Hg ranked #1 and #2, respectively, as the safest target for the outcome of serious adverse effects. Cluster plots for combined efficacy and safety showed that a systolic BP target of &lt;130 mm Hg had optimal balance between efficacy and safety.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">In patients with hypertension, a on-treatment systolic BP target of &lt;130 mm Hg achieved optimal balance between efficacy and safety.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2017 Elsevier Inc. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Bangalore</LastName>\n                    <ForeName>Sripal</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, New York University School of Medicine, New York, NY. Electronic address: sripalbangalore@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Toklu</LastName>\n                    <ForeName>Bora</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, Mount Sinai Beth Israel Medical Center, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gianos</LastName>\n                    <ForeName>Eugenia</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, New York University School of Medicine, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schwartzbard</LastName>\n                    <ForeName>Arthur</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, New York University School of Medicine, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Weintraub</LastName>\n                    <ForeName>Howard</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, New York University School of Medicine, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ogedegbe</LastName>\n                    <ForeName>Gbenga</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, New York University School of Medicine, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Messerli</LastName>\n                    <ForeName>Franz H</ForeName>\n                    <Initials>FH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Cardiology, University Hospital, Bern, Switzerland; Division of Cardiology, Mount Sinai, Icahn School of Medicine, New York, NY.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017418">Meta-Analysis</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>01</Month>\n                <Day>19</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Am J Med</MedlineTA>\n            <NlmUniqueID>0267200</NlmUniqueID>\n            <ISSNLinking>0002-9343</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000959">Antihypertensive Agents</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>AIM</CitationSubset>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Ann Intern Med. 2017 Jun 20;166(12 ):JC64</RefSource>\n                <PMID Version="1">28630976</PMID>\n            </CommentsCorrections>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>J Public Health Emerg. 2017 Jun;1:</RefSource>\n                <PMID Version="1">30148257</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000959" MajorTopicYN="N">Antihypertensive Agents</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000071076" MajorTopicYN="N">Network Meta-Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>\n                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Blood pressure</Keyword>\n            <Keyword MajorTopicYN="Y">Myocardial infarction</Keyword>\n            <Keyword MajorTopicYN="Y">Stroke</Keyword>\n            <Keyword MajorTopicYN="Y">Systolic</Keyword>\n            <Keyword MajorTopicYN="Y">Target</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2016</Year>\n                <Month>05</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>01</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>01</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>1</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2017</Year>\n                <Month>8</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>1</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">28109971</ArticleId>\n            <ArticleId IdType="pii">S0002-9343(17)30035-9</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.amjmed.2017.01.004</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'